Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Norovirus Acute Gastroenteritis: full-pipeline trial registry
1 of 2 indexed Norovirus Acute Gastroenteritis trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Norovirus Acute Gastroenteritis: 2 US clinical trials tracked, 1 recruiting.
Norovirus Acute Gastroenteritis is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is ModernaTX, running 2 of these trials.
Enrollment posture brief
Registry condition norovirus-acute-gastroenteritis
OPEN 1 | RECR 50% | LATE 1 | EARLY 1 | RANK #7188 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Norovirus Acute Gastroenteritis lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Norovirus Acute Gastroenteritis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Norovirus Acute Gastroenteritis is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
ModernaTX
NCT05992935
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
ModernaTX
NCT06592794
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Norovirus Acute Gastroenteritis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Norovirus Acute Gastroenteritis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Norovirus Acute Gastroenteritis page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Norovirus Acute Gastroenteritis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- ModernaTX sponsors the most Norovirus Acute Gastroenteritis trials on record, review their full trial history before evaluating a specific study. See ModernaTX's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Norovirus Acute Gastroenteritis condition card totals 2 registered trials; most-linked intervention mRNA-1403; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.